A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis.
Kieun BaeJin Hee KimHyojik JungSun-Young KongYun-Hee KimSunshin KimGeon Kook LeeJin Soo LeeJake June-Koo LeeYoung Seok JuYang-Kyu ChoiKyong-Ah YoonPublished in: British journal of cancer (2020)
Taken together, our results suggest a newly identified fusion gene, CD63-BCAR4 as a potential novel oncogene in lung adenocarcinoma.